**5.7 Others abnormalities**

According to the IPSS, other abnormalities can be considered as favourable:


Thus, chromosomal aberrations still have clinical relevance in MDS even in the era of genomic medicine. Because they basically consist in copy number changes, their detection will likely be improved by array-based karyotyping and/or by massive parallel sequencing itself [16].
